Login / Signup
Editorial: evolution of GLP-1 receptor agonists as pharmacotherapy for NASH beyond diabetes mellitus and obesity.
Won Kim
Published in:
Alimentary pharmacology & therapeutics (2021)
Keyphrases
</>
insulin resistance
metabolic syndrome
weight loss
type diabetes
high fat diet induced
weight gain
glycemic control
smoking cessation
body mass index
adipose tissue